Meta-analysis of [18F]FDG-PET/CT in pulmonary sarcoidosis - Takeaways - MDSpire

Meta-analysis of [18F]FDG-PET/CT in pulmonary sarcoidosis

  • By

  • Ryan Donnelly

  • Michael McDermott

  • Gerry McManus

  • Alessandro N. Franciosi

  • Michael P. Keane

  • Emmet E. McGrath

  • Cormac McCarthy

  • David J. Murphy

  • July 23, 2024

  • 0 min

Share

  • 1

    Sarcoidosis is a multisystem inflammatory disease characterized by non-necrotizing granulomas, with pulmonary involvement being the most common manifestation.

  • 2

    Accurate diagnosis of pulmonary sarcoidosis is challenging due to variable clinical presentations and the need for histological confirmation.

  • 3

    FDG-PET/CT is a sensitive imaging method that can detect inflammation in sarcoidosis, sometimes before anatomical changes are visible.

  • 4

    This meta-analysis aims to evaluate the diagnostic performance of FDG-PET/CT in suspected pulmonary sarcoidosis and its correlation with clinical biomarkers.

  • 5

    The study includes a systematic review of literature assessing FDG-PET/CT's diagnostic accuracy and prognostic value in pulmonary sarcoidosis.

Original Source(s)

Meta-analysis of [18F]FDG-PET/CT in pulmonary sarcoidosis

  • by Ryan Donnelly, Michael McDermott, Gerry McManus, Alessandro N. Franciosi, Michael P. Keane, Emmet E. McGrath, Cormac McCarthy, David J. Murphy

  • July 23, 2024

Related Content

Can MRI Predict Perforator Stroke Progression?

Investigators evaluate multisequence imaging for its ability to identify patients at risk for neurologic progression.

Mammography AI Spots Vascular Signals

Routine breast imaging offers opportunity for cardiovascular risk assessment.

LV Function Mostly Preserved After ASO

CMR findings were largely reassuring in most patients, although late gadolinium enhancement was identified in a minority.